Impaired pubertal development and testicular hormone function in males with sickle cell anemia

What Was Tested

This randomized controlled trial paper looks at hCG (human chorionic gonadotropin) in the context of anemia.

This study aimed to evaluate the clinical and laboratory views of the Leydig cells function after stimulation with hCG in adults with sickle cell disease.

Why It Was Studied

The control group, composed by adult males, was divided into two groups: I - 10 relatives (18-39 years, median=26 years) with the same socioeconomic level of the patients, and II - 9 normal individuals (23-28, median=31 years) randomly chosen.

Who Took Part

The abstract describes 15 patients taking part.

By PubMed's age tags, the people studied were teenagers and adults, men only.

How the Study Was Run

The researchers set it up as a randomized study.

Random assignment meant chance, not the researchers, decided who got hCG (human chorionic gonadotropin) and who got the comparison, which limits bias.

What Was Measured

The control group, composed by adult males, was divided into two groups: I - 10 relatives (18-39 years, median=26 years) with the same socioeconomic level of the patients, and II - 9 normal individuals (23-28, median=31 years) randomly chosen.

The subject headings attached to it are Anemia, Sickle Cell, Chorionic Gonadotropin, Hypogonadism, Leydig Cells, Puberty, Reproductive Control Agents and Testosterone.

Author keywords: Hypoandrogenism, Pubertal development, Sickle cell disease and Testicular hormonal function.

What This Means in Plain Language

The paper is a randomized study of hCG (human chorionic gonadotropin) in 15 patients in people with anemia.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2015 (Blood cells, molecules & diseases), a journal based in United States.

More context: the hCG (human chorionic gonadotropin) compound page, Anemia research.